Effects of Inonotus Obliqua Extract on Blood Glucose Levels in Genetically Diabetic Mice

차가버섯 추출물이 당뇨생쥐 $(C57BL/KsJ^-m^{+/+}Lepr^{db})$의 혈당수준에 미치는 영향

  • Hong, Hee-Ok (Department of Food Service Management and Nutrition, Sangmyung University)
  • 홍희옥 (상명대학교 생활환경학부 외식영양학과)
  • Published : 2007.10.30

Abstract

This study investigated the therapeutic effects of Inonotus obliqua extract on blood glucose, insulin, and other biochemical parameters in genetically diabetic mice $(C57BL/KsJ^-m^{+/+}Lepr^{db})$. The mice were divided into four groups-control, Chaga 1 (dose of 0.09 mg/kg of body weight), Chaga 5 (5 times of Chaga 1), and Chaga 10 (10 times of Chaga 1) - according to supplemented dose. Inonotus obliqua extract was orally administered to the animals for 6 weeks. The body and organ (liver and kidney) weights were not different among groups. Fasting blood glucose level was significantly lower in the Chaga 5 group compared with the control (p < 0.05). Hemoglobin A1c content was significantly lower in the Chaga 5 group compared with either the control and Chaga 1 group (p < 0.05). There was no significant difference in serum insulin level among groups. The glucose-6-phosphatase activity in liver was significantly the lowest in Chaga 10 group and was significantly lower in Chaga 5 group as compared with those of control and Chaga 1 groups. Therefore, the results of this study demonstrate that Inonotus obliqua extract alleviates many of the symptoms of diabetes in genetically obese mice and may offer a possibility as a therapeutic supplement for the normalization of blood glucose levels in human with hyperglycemia and have beneficial effects in patients with non-insulin-dependent diabetes mellitus.

Keywords

References

  1. Zabriskie P. Diabetes is becoming an asian epidemic, and its victims are younger than ever. What's behind the crisis? Time 2002; 160
  2. National health and nutrition survey report in summary report of the cause of death statistics in 2003, Korea National Statistical Office, Seoul, 2004
  3. Ministry and health welfare. '98 National health and nutrition survey report. Korea Institute for Health and Social Affairs, 1999
  4. Furuse H, Kimura C, Mabayo RT, Takahashi H, Okumura J. Dietary sorbose prevents and improves hyperglycemia in genetically diabetic mice. J Nutr 1993; 123: 59-65 https://doi.org/10.1093/jn/123.1.59
  5. Mizuno T, Zhuang C, Abe K, Okamoto H, Kiho T, Dkai S, Leclerc S, Meijer L. Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus (Pers.: r.) PH (Aphyllophoromycetidae). Int J Med Mushrooms 1999; 1: 301-318 https://doi.org/10.1615/IntJMedMushr.v1.i4.20
  6. Babitskaya VG, Scherba VV, Ikonnikova NV, Bisno NA, Mitropolskaya NY. Melanin complex from medicinal mushroom Inonotus obliquus (Pers.: Fr.) Pilat (Chaga) (Aphyllophoromycetidae). Int J Med Mushrooms 2002; 4: 139-145
  7. Takashi M, Cun Z, Kuniaki A, Hidehumi 0, Tadash K, Shigeo D, Sophie L, Laurent M. Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of inonotus obliquus (Pers.: Fr.) Pil (Aphyllophoromycetidae). Int J Med Mushrooms 1999; 1: 301-316 https://doi.org/10.1615/IntJMedMushr.v1.i4.20
  8. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetic Care 1989; 12: 553-564 https://doi.org/10.2337/diacare.12.8.553
  9. Cui Y,Kim OS, Park KC. Antioxidant effect ofInonotus obliquus. Journal of Ethnopharmacology 2005; 96: 79-85 https://doi.org/10.1016/j.jep.2004.08.037
  10. Kahlos K. Inonotus obliquus (Chaga Fungus): Culture and the production of inotodio, sterols, and other secondary metabolites. Biotechnology in Agriculture and Forestry 1994; 26: 179-198
  11. Sliva D. Cellular and physiological effects of ganoderma lucidum (Reishi). Medicinal Chemistry 2004; 4: 873-879
  12. McCarty MF. Nutraceutical resources for diabetes prevention-an update. Med Hypotheses 2005; 64: 151-158 https://doi.org/10.1016/j.mehy.2004.03.036
  13. Salmeron J. Manson JE. Stampfer MJ. Colditz GA., Wing AI. Willett WC. Dietary fiber, glycemic load, and risk of noninsulindependent daibetes mellitus in women. JAMA 1997; 277: 472477 https://doi.org/10.1001/jama.277.6.472
  14. Johnston KL, Clifford MN, Morgan LM. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 2003; 78: 728-733 https://doi.org/10.1093/ajcn/78.4.728
  15. Lee SC. Gepts PL. Whitaker JR. Protein structures of common bean (Phaseolus vulgaris) alpha-amylase inhibitors. J Agric Food Chem 2002; 50: 6618-6627 https://doi.org/10.1021/jf020189t
  16. Fryer LG, Parbu PA. Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 2002; 277: 25226-25232 https://doi.org/10.1074/jbc.M202489200
  17. Gabbay KH, Hasty K, Breslow HL, Ellison RC, Bunn HF, Gallop PM. Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab 1997; 44: 859-864 https://doi.org/10.1210/jcem-44-5-859
  18. Miyake K, Ogawa W, Matsumoto M, Nakamura T, Sakaue H, Kasuga M. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J Clin Invest 2002; 110: 1483-1491 https://doi.org/10.1172/JCI0215880
  19. Robbo E, Terkildsen TC. On the enzymatic determination of blood glucose. Scad J Lab Invest 1968; 12: 402-407
  20. Baginski ES, Foa PP,Zak R. Glucose 6-phosphatase. In: Methods of Enzymatic Analysis. New York: Academic Press; 1993. p.876-880
  21. Hong H, Maeng WJ. Effects of malted barley extract and banaba extract on blood glucose levels in genetically diabetic mice. J Med Food 2004; 7: 487-490 https://doi.org/10.1089/jmf.2004.7.487
  22. Hyun DY. Effects of Tchaga Unonotus-obliquus) extract on Streptozotocin induced diabetic rats. Ph. D. thesis, Chungnam National University, 2004
  23. Im SJ, Kim GJ. Hypoglycemic effect of polygonatum odoratum var. pluriflorum ohwi extract in streptozotocin-induced diabetic rats. Korean J Nutr 1995; 28: 727-736
  24. Seyer-Hansen K. Renal hypertrophy in streptozotocin-diabetic rats. Clin Sci Mol Med 1976; 51: 551-555
  25. Mogensen CE, Annderson MJE. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 1973; 22: 706-712 https://doi.org/10.2337/diab.22.9.706
  26. Mizuno T, Zhuang C, Abe K, Okamoto H, Kiho T, Ukai S, Leclerc S, Meijer L. ANtitumor and hypoglycemic activities of polysaccharides isolated from sclerotium 'Chaga' and mycelium of Fuscoporia obliqua mushroom fungus. きのこの科學 1996;3: 53-60
  27. Lee YS. Laboratory animal medicine: Press of Seoul National University. Seoul; 1997. p.l56-157
  28. Kim WJ, Min HG, Choi YK, Lee TH, Huh KB, Shin SH. Diabetes: Korean Diabetes Association. Seoul; 1998. p.307
  29. Suzuki Y, Unno T, Ushitani M, Hayashi K, Kakuda T. Antiobesity activity of extracts from Lagerstroemia speciosa L. leaves on female KK-Ay mice. J Nutritional Science and Vitaminology 1999; 45: 791-795 https://doi.org/10.3177/jnsv.45.791
  30. Fryer LGD, Hajduch E, Rencurel F, Salt IP, Hundal HS, Hardie DG, Carling D. Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes 2000;49: 1978-1985 https://doi.org/10.2337/diabetes.49.12.1978
  31. Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes. Am J Physiol 1999; 277: E1-E10
  32. Ojuka EO, Jones TE, Nolte LA, Chen M, WamhoffBR, Sturex M, Holloszy JO. Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca2+. Am J Physiol Endocrinol Metab 2002; 282: E1008-E1013
  33. Massillon O, Barzilai N, Chen W. Glucose regulates in vivo glucose 6-phosphatase gene expression in the liver of diabetic rats. J Biol Chem 1996; 71: 9871-9874